Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy.

Objective. To determine the influence of comorbidity on survival in early-stage lung cancer patients treated with proton radiotherapy, using the Charlson Comorbidity Index. Study Design and Setting.